BACKGROUND: The eld of research into the probable link between androgenetic alopecia (AGA) and metabolic syndrome (MetS) is rapidly
expanding. The exact underlying pathogenesis yet to be identi ed. Alarin, a galanin neuropeptide, found to be elevated in patients with metabolic
syndrome and may represent a potential link between AGA and MetS. OBJECTIVE: The aim of this study was to assess serum levels of alarin
in patients with AGA and investigate its possible correlation, if any, with criteria of MetS in those patients. METHODS: The study included 50
male patients with AGA and 30 healthy controls. Weight, height, waist circumference, and body mass index (BMI) were all measured. Systolic
and diastolic blood pressure readings were recorded. Serum level of lipids, fasting blood glucose (FBG) and alarin were also assessed. RESULTS:
Anthropometric measures, serum lipids, FBG, and serum alarin were much higher in patients with AGA compared to controls (p |
